Amgen Drives U.S. Manufacturing Leadership
Amgen is bringing economic growth to the local economy and workforce in Ohio.
Amgen has announced a significant investment in Central Ohio, to expand the state’s cutting-edge biomanufacturing facility and create 350 new high-quality jobs, bringing the facility total to 750 employees. This latest milestone pushes Amgen’s commitment in the state to over $1.4 billion, bolstering the surrounding economy of Columbus while advancing U.S. biopharmaceutical manufacturing leadership.
By planting deep roots in Ohio, Amgen opens doors for high-paying STEM careers in the region. Amgen’s innovative apprenticeship program cultivates local talent through hands-on, specialized training that leads directly to full-time careers. The program bridges the tech workforce gap and empowers the next generation of STEM professionals.
Amgen is at the forefront of innovation, developing medicines to solve some of the world’s toughest diseases and paving the way to bring next-generation therapies to patients. By investing in American manufacturing, Amgen is bringing home the innovative work of discovering new medicines for years to come.
See how Amgen is investing in innovation, workforce development and the community in Central Ohio.

Our Work in Action
To maintain America’s global leadership, we need to support the next generation of innovation in medicine.